NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/25/2025
Back to search
Official data from USPTO
CROSSBOW THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CROSSBOW THERAPEUTICS
ST13
US500000097087376Class
5
Filing
97087376
Registration
8042890
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
11/26/2025
Trademark type
Word
Nice classes
5
Filing date
10/22/2021
Registration date
11/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/25/2025
Last transaction
11/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/10/2025
First use in commerce
07/10/2025
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
SENSOR,JAMES EARL
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Crossbow Therapeutics, Inc.
Representatives
Michael R. Graif Brown Rudnick LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of cancer and immunological diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention and treatment of cancer and immunological diseases and disorders; Pharmaceutical preparationsantivirals
Publications
History of USPTO decisions and trademark events.
57 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/03/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/10/2025
IUAF
USE AMENDMENT FILED
09/28/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/28/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/13/2025
EX5G
SOU EXTENSION 5 GRANTED
03/13/2025
EXT5
SOU EXTENSION 5 FILED
03/03/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/04/2024
EX4G
SOU EXTENSION 4 GRANTED
09/04/2024
EXT4
SOU EXTENSION 4 FILED
09/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/06/2024
EX3G
SOU EXTENSION 3 GRANTED
03/04/2024
EXT3
SOU EXTENSION 3 FILED
03/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/13/2023
EX2G
SOU EXTENSION 2 GRANTED
09/11/2023
EXT2
SOU EXTENSION 2 FILED
09/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/09/2023
EX1G
SOU EXTENSION 1 GRANTED
08/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/07/2023
NREV
NOTICE OF REVIVAL - E-MAILED
06/26/2023
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
06/25/2023
PETG
PETITION TO REVIVE-GRANTED
06/25/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
06/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/15/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/15/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/15/2023
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06/12/2023
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/12/2023
EXT1
SOU EXTENSION 1 FILED
05/08/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/08/2022
DOCK
ASSIGNED TO EXAMINER
08/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2021
NWAP
NEW APPLICATION ENTERED
10/26/2021
Continuous trademark protection
Get notified about every new filing that threatens CROSSBOW THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.